AGEN1884, an IgG1 anti-CTLA-4 antibody, combines effectively with PD-1 blockade in primary...

Anti-PD-1 antibodies and methods of use thereof

M Van Dijk, NS Wilson, CA Mundt, G Ritter… - US Patent …, 2019 - Google Patents
The instant disclosure provides antibodies that specifically bind to human PD-1 and
antagonize PD-1 function. Also provided are pharmaceutical compositions comprising these …
被引用次数：21 相关文章 所有 4 个版本

Anti-PD-1 antibodies and methods of use thereof

M Van Dijk, CA Mundt, G Ritter, JD Wolchok… - US Patent …, 2022 - Google Patents
2021-03-30 Assigned to MEMORIAL SLOAN KETTERING CANCER CENTER reassignment
MEMORIAL SLOAN KETTERING CANCER CENTER ASSIGNMENT OF ASSIGNORS …
被引用次数：1 相关文章 所有 4 个版本

Antibodies and methods of use thereof

M Van Dijk, CA Mundt, G Ritter, D Schaer… - US Patent …, 2024 - Google Patents
Provided are antibodies that specifically bind to CTLA-4 and/or PD-1 and antagonize CTLA-
4 and/or PD-1 function. Also provided are pharmaceutical compositions and kits comprising …
相关文章 所有 4 个版本

Anti-PD-1 antibodies and methods of use thereof

M Van Dijk, CA Mundt, G Ritter, JD Wolchok… - US Patent …, 2019 - Google Patents
The instant disclosure provides antibodies that specifically bind to human PD-1 and
antagonize PD-1 function. Also provided are pharmaceutical compositions comprising these …
相关文章 所有 4 个版本